BREATHE-BRinging Exercise, Asthma Assessments, TeacHing to Everyone

项目摘要/摘要 哮喘是一种长期的肺部疾病，会导致咳嗽、喘息、胸闷和呼吸急促。 由于炎症或支气管痉挛导致呼吸道狭窄。哮喘是一种日益严重的慢性疾病，影响 美国有3000万人，其中2000万人(占美国人口的9%)是成年人。成年人有五倍于此的可能性 比儿童更容易死于哮喘。三分之一的成人哮喘患者有过哮喘发作，大约有10个人 每天都死于哮喘。虽然哮喘无法治愈，但它是可以控制的。根据全球倡议 哮喘的管理和预防(GINA)报告，哮喘通过重复评估周期得到最好的管理， 针对哮喘症状、危险因素和合并症的干预措施的治疗和调整。教育也是 推荐给所有哮喘患者，并已被证明可以减少计划外看医生，缺勤天数， 与哮喘相关的急诊科就诊、住院，并提高生活质量。这个问题只有21%的成人哮喘患者 接受哮喘教育的成年人和有健康差距的人的人数较少。有了资金 根据NIH/NHLBI快速通道拨款(R44HL137502)，我们开发了一个COPD自我管理平台，用于虚拟 肺康复。该产品目前处于临床试验阶段，初步结果令人振奋。这 应用程序的广泛、长期目标是利用Blue Marble Health慢性病自我管理 开发平台开发呼吸，这是一种哮喘自我管理工具，将包括与哮喘有关的教育， 评估、锻炼和行动计划。目标1：利用中小企业的意见来设计和开发呼吸。目标2：评估 呼吸的可行性和可用性，并评估呼吸在多大程度上包括小规模的成年人和 那些有健康差距的人。参与者将包括主题专家，如患有哮喘和医疗保健的成年人 是哮喘专家的专业人士。参与者将完成为期2周的哮喘自我管理工具，并 使用系统可用性量表(SUS)评估其可用性。成功的基准包括SUS平均分65分 百分位数，平均净推广者分数&>5，只有不到50%的研究参与者在下载 应用程序到他们的个人设备，50%或更多的参与者会同意Dei得到了很好的解决，50%或更多的参与者会同意 参与者将报告他们考虑过改变行为。与NHLBI任务有关的相关性 与健康相关的是，哮喘是一种代价高昂的疾病，往往管理不善，这一点在 将成年人和有健康差距的人分成几组。此应用程序还直接处理NHLBI SBIR请求 关于开发工具和平台以改进证据的传播和实施的建议-- 以肺部疾病和失调为基础的干预。

Project Summary /Abstract Asthma is a long-term lung disease that causes episodes of coughing, wheezing, chest tightness, and shortness of breath due to inflammation or bronchospasms that narrow the airways. Asthma is a growing chronic condition that affects over 30 million people in the US, and 20 million (9% of the US population) of whom are adults. Adults are five times more likely to die from asthma than children. A third of adults with asthma have had an asthma attack and approximately ten people die every day from asthma. While asthma cannot be cured, it can be managed. According to Global Initiative for Management and Prevention of Asthma (GINA) report, asthma is best managed with repeated cycles of assessment, treatment, and adjustment of interventions for asthma symptoms, risk factors, and comorbidities. Education is also recommended for all people with asthma and has been shown to reduce unscheduled doctor visits, days of missed work, asthma-related ED visits, hospitalization, and to also improve quality of life. The problem is only 21% of adults with asthma receive asthma education and the number is lower with minoritized adults or those with health disparities. With funding from an NIH/NHLBI Fast-Track grant (R44HL137502), we developed a COPD self-management platform for use with virtual pulmonary rehabilitation. This product is now in the clinical trial phase with promising preliminary results. This application’s broad, long-term objectives are to leverage the Blue Marble Health chronic disease self-management platform to develop BREATHE, an Asthma self-management tool which will include asthma-related education, assessments, exercise, and an action plan. Aim 1: Use input from SMEs to design and develop BREATHE. Aim 2: Evaluate the feasibility and usability of BREATHE and evaluate the extent to which BREATHE is inclusive of minoritized adults and those with health disparities. Participants will include subject matter experts such as adults with asthma and healthcare professionals who are asthma experts. Participants will complete the asthma self-management tool for 2 weeks and evaluate its usability using the System Usability Scale (SUS). Benchmark for success include a mean SUS score of >65th percentile, mean net promoter score >5, less than 50% of the study participants will have trouble with downloading the app to their personal device, 50% or more participants will agree that DEI was addressed well, and 50% or more participants will report that they considered making a behavior change. The relevance to the NHLBI mission related to health relatedness, is that asthma is a costly condition that is often poorly managed, and this is more pronounced in minoritized adults and those with health disparities. This application also directly addresses the NHLBI SBIR requests for proposals for the development of tools and platforms to improve the dissemination and implementation of evidence- based interventions for lung diseases and disorders.